[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB0113297D0 - Chemical Process - Google Patents

Chemical Process

Info

Publication number
GB0113297D0
GB0113297D0 GBGB0113297.6A GB0113297A GB0113297D0 GB 0113297 D0 GB0113297 D0 GB 0113297D0 GB 0113297 A GB0113297 A GB 0113297A GB 0113297 D0 GB0113297 D0 GB 0113297D0
Authority
GB
United Kingdom
Prior art keywords
chemical process
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0113297.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GBGB0113297.6A priority Critical patent/GB0113297D0/en
Publication of GB0113297D0 publication Critical patent/GB0113297D0/en
Priority to PCT/GB2002/002516 priority patent/WO2002096916A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0113297.6A 2001-06-01 2001-06-01 Chemical Process Ceased GB0113297D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0113297.6A GB0113297D0 (en) 2001-06-01 2001-06-01 Chemical Process
PCT/GB2002/002516 WO2002096916A1 (en) 2001-06-01 2002-05-29 Process for phosphorylation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0113297.6A GB0113297D0 (en) 2001-06-01 2001-06-01 Chemical Process

Publications (1)

Publication Number Publication Date
GB0113297D0 true GB0113297D0 (en) 2001-07-25

Family

ID=9915676

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0113297.6A Ceased GB0113297D0 (en) 2001-06-01 2001-06-01 Chemical Process

Country Status (2)

Country Link
GB (1) GB0113297D0 (en)
WO (1) WO2002096916A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04002303A (en) 2001-09-11 2004-06-29 Astrazeneca Ab Oxazolidinone and/or isoxazoline as antibacterial agents.
EP1443930A1 (en) 2001-10-25 2004-08-11 AstraZeneca AB Isoxazoline derivatives useful as antimicrobials
AR038536A1 (en) 2002-02-25 2005-01-19 Upjohn Co N-ARIL-2-OXAZOLIDINONA-5- CARBOXAMIDS AND ITS DERIVATIVES
US7141588B2 (en) 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
PL372090A1 (en) 2002-02-28 2005-07-11 Astrazeneca Ab Chemical compounds
KR20040087329A (en) 2002-02-28 2004-10-13 아스트라제네카 아베 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents
TW200420573A (en) 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
EP1625124A1 (en) * 2003-05-06 2006-02-15 Ranbaxy Laboratories, Ltd. Oxazolidinone derivatives as antimicrobials
ES2393292T3 (en) 2003-06-03 2012-12-20 Rib-X Pharmaceuticals, Inc. Heterocyclic biaryl compounds and methods of obtaining and using them
US8324398B2 (en) 2003-06-03 2012-12-04 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
US7304050B2 (en) 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
US7129259B2 (en) 2003-12-17 2006-10-31 Rib-X Pharmaceuticals, Inc. Halogenated biaryl heterocyclic compounds and methods of making and using the same
CN102816194A (en) 2004-02-27 2012-12-12 瑞伯-X医药品有限公司 Macrocyclic compounds and methods of making and using the same
WO2006133397A2 (en) 2005-06-08 2006-12-14 Rib-X Pharmaceuticals, Inc. Process for the synthesis of triazoles
WO2011024004A1 (en) * 2009-08-26 2011-03-03 Astrazeneca Ab Heterocyclic urea derivatives useful for treatment of bacterial infection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999064417A2 (en) * 1998-06-05 1999-12-16 Astrazeneca Ab Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
GB9928499D0 (en) * 1999-12-03 2000-02-02 Zeneca Ltd Chemical processes and intermediates

Also Published As

Publication number Publication date
WO2002096916A1 (en) 2002-12-05

Similar Documents

Publication Publication Date Title
GB0111020D0 (en) Process
GB0109555D0 (en) Process
GB0113297D0 (en) Chemical Process
HUP0103089D0 (en) Chemical process
GB0112792D0 (en) Process
GB0102109D0 (en) Chemical process
GB0114408D0 (en) Chemical process
GB0112801D0 (en) Process
GB0130517D0 (en) Chemical process
GB0112331D0 (en) Process
GB0125473D0 (en) Chemical process
GB0112789D0 (en) Process
GB0110411D0 (en) Chemical process
GB0017979D0 (en) Chemical process
GB0102107D0 (en) Chemical process
HU0103088D0 (en) Chemical process
GB0130285D0 (en) Chemical process
GB0130286D0 (en) Chemical process
GB0102108D0 (en) chemical process
GB0112327D0 (en) Process
HU0101588D0 (en) Chemical process
GB0111606D0 (en) Chemical process
GB0113295D0 (en) Chemical process
GB0120684D0 (en) Chemical process
HU0103122D0 (en) Chemical process chemical process chemical process

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)